---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-076793"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-03-22T23:59:59+00:00"
generated_at: "2026-06-17T21:06:18.017546+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Elevance Health to reaffirm FY2023 guidance and discuss 2027 targets

## Summary
- Investor conference on March 23, 2023; webcast at 8:00 a.m. ET.
- FY2023 guidance reaffirmed; no new financial figures provided in filing.
- Long-term financial targets through 2027 to be discussed.
- No specific numbers or changes disclosed; filing is procedural FD disclosure.

## SEC filing metadata
- accession: 0001193125-23-076793
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312523076793/0001193125-23-076793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312523076793/d483237d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-076793
- JSON: https://secwatch.observer/filing/0001193125-23-076793.json
- Plain text: https://secwatch.observer/filing/0001193125-23-076793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.